Tekla Life Sciences Investors Stock Forecast
Tekla Life Sciences Investors stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session.
(Updated on May 01, 2024)
The Tekla Life Sciences Investors stock price gained 1.53% on the last trading day (Wednesday, 1st May 2024), rising from $13.08 to $13.28. During the last trading day the stock fluctuated 3.20% from a day low at $13.02 to a day high of $13.44. The price has risen in 6 of the last 10 days and is up by 3.83% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 13 thousand more shares were traded than the day before. In total, 56 thousand shares were bought and sold for approximately $744.32 thousand.
Given the current short-term trend, the stock is expected to fall -8.22% during the next 3 months and, with a 90% probability hold a price between $11.56 and $12.19 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HQL Signals & Forecast
Mostly positive signals in the chart today. The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $13.09 and $13.24. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 3.83%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Tekla Life Sciences Investors has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
Tekla Life Sciences Investors finds support from accumulated volume at $13.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.416 between high and low, or 3.20%. For the last week the stock has had daily average volatility of 1.41%.
Our recommended stop-loss: $12.59 (-5.17%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 10 days ago.)
Trading Expectations (HQL) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Tekla Life Sciences Investors to open at $13.25, and during the day (based on 14 day Average True Range), to move between $13.10 and $13.46, which gives a possible trading interval of +/-$0.181 (+/-1.36%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.72% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $13.10 (1.36%) than the resistance at $13.82 (4.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tekla Life Sciences Investors stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.
Current score: 1.969 Buy Candidate Upgraded
Predicted Opening Price for Tekla Life Sciences Investors of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $13.25 ( 0.261%) | $13.28 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.66 | 2.87 % | |
| R2 | 13.50 | 1.68 % | ||
| R1 | 13.40 | 0.94 % | ||
| Current price: | 13.28 | |||
| Support | S1 | 13.09 | -1.46 % | |
| S2 | 12.99 | -2.20 % | ||
| S3 | 12.83 | -3.39 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 14.11 | 6.25 % | |
| R2 | 13.90 | 4.67 % | ||
| R1 | 13.82 | 4.07 % | ||
| Current price | 13.28 | |||
| Support | S1 | 13.10 | -1.36% | |
| S2 | 12.97 | -2.33% | ||
| S3 | 12.79 | -3.69% |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 21, 2024 | Feb 21, 2024 | Mar 28, 2024 | $0.390 | 2.86% |
| 2 | Nov 09, 2023 | Nov 21, 2023 | Jan 10, 2024 | $0.300 | 2.09% |
| 3 | Aug 15, 2023 | Aug 24, 2023 | Sep 29, 2023 | $0.320 | 2.57% |
| 4 | May 15, 2023 | May 24, 2023 | Jun 30, 2023 | $0.320 | 2.36% |
| 5 | Feb 15, 2023 | Feb 24, 2023 | Dec 31, 2018 | $0.330 | 2.18% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
